AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Appili Therapeutics Inc.

CAD 0.01 -$0.02 (-60.00%)
TSX · 14 Sep 2026 20:10 UTC
Previous Close
CAD 0.01
Day Range
CAD 0.01 - CAD 0.01
Year Range
CAD 0.01CAD 0.04
Market Cap
1.32M
AVG Volume
56.6K
Trailing/Forward PE
-0.28/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Toronto Stock ExchangeCA
Revenue (CAD) · TTM
0250K500K750K1M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Revenue (CAD) · TTM by quarter
PeriodRevenue (CAD) · TTM
27 Q1378.81K
26 Q4260.91K
26 Q3206.31K
26 Q2199.69K
26 Q1100.44K
25 Q4100.44K
25 Q3124.75K
25 Q2494.78K
25 Q1827.41K
24 Q4827.41K
Net Income (CAD) · TTM
-6M-4M-2M024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Net Income (CAD) · TTM by quarter
PeriodNet Income (CAD) · TTM
27 Q1-4.68M
26 Q4-4.23M
26 Q3-2.96M
26 Q2-2.53M
26 Q1-2.29M
25 Q4-2.62M
25 Q3-3.96M
25 Q2-3.58M
25 Q1-3.82M
24 Q4-3.78M
Operating Income (CAD) · TTM
-8M-6M-4M-2M02M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Operating Income (CAD) · TTM by quarter
PeriodOperating Income (CAD) · TTM
27 Q1-6.08M
26 Q4-5.52M
26 Q3-3.13M
26 Q2-1.92M
26 Q1-946.3K
25 Q4106.25K
25 Q3-2.25M
25 Q2-2.59M
25 Q1-2.68M
24 Q4-4.91M
EBITDA (CAD) · TTM
-6M-4M-2M02M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO EBITDA (CAD) · TTM by quarter
PeriodEBITDA (CAD) · TTM
27 Q1-5.86M
26 Q4-4.97M
26 Q3-1.59M
26 Q2-881.13K
26 Q1-18.03K
25 Q4360.57K
25 Q3-1.28M
25 Q2-972.27K
25 Q1-1.27M
24 Q4-2.07M
Cash Flows (CAD) · TTM
-3M-2M-1M01M24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Cash Flows (CAD) · TTM by quarter
PeriodCash Flows (CAD) · TTM
27 Q1-1.32M
26 Q4-1.32M
26 Q3-24.57K
26 Q2-174.57K
26 Q1992.17K
25 Q4866.46K
25 Q3-641.51K
25 Q254.81K
25 Q1-589.7K
24 Q4-2.51M
EPS (CAD) · TTM
-0.04-0.03-0.02-0.01024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO EPS (CAD) · TTM by quarter
PeriodEPS (CAD) · TTM
27 Q1-0.04
26 Q4-0.03
26 Q3-0.02
26 Q2-0.02
26 Q1-0.02
25 Q4-0.02
25 Q3-0.03
25 Q2-0.03
25 Q1-0.03
24 Q4-0.03
Expenses (CAD) · TTM
-5M05M10M15MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Expenses (CAD) · TTM by quarter
PeriodExpenses (CAD) · TTM
27 Q16.42M
26 Q46.33M
26 Q36.36M
26 Q27.69M
26 Q19M
25 Q410.18M
25 Q310.08M
25 Q210.37M
25 Q19.55M
24 Q49.09M
Shares Outstanding · TTM
-200K-150K-100K-50K024 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q427 Q1
APLI.TO Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
27 Q1-22.67K
26 Q4-40.77K
26 Q3-51.46K
26 Q2-53.19K
26 Q1-55.88K
25 Q4-117.8K
25 Q3-117.16K
25 Q2-122.03K
25 Q1-124.01K
24 Q4-191.35K
Free Cash Flow Yield
-150%-100%-50%0%50%med -1.28%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
APLI.TO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-100.01%
Sep 26-100.01%
Aug 26-66.67%
Aug 26-66.67%
Aug 26-100.01%
Aug 26-100.01%
Jul 26-66.67%
Jul 26-100.01%
Jul 26-66.67%
Jul 26-66.67%
Jul 26-66.67%
Jun 26-1.28%
Jun 26-1.28%
Jun 26-1.28%
Jun 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-1.28%
May 26-0.96%
Apr 26-1.28%
Apr 26-1.28%
Apr 26-1.28%
Apr 26-0.96%
Mar 26-7.2%
Mar 26-9.6%
Mar 26-7.2%
Mar 26-7.2%
Feb 26-9.6%
Feb 26-7.2%
Feb 26-7.2%
Feb 26-5.76%
Jan 26-5.76%
Jan 26-7.2%
Jan 26-7.2%
Jan 26-7.2%
Jan 26-5.76%
Dec 2532.73%
Dec 2540.91%
Dec 2532.73%
Dec 2532.73%
Nov 2532.73%
Nov 2532.73%
Nov 2532.73%
Nov 2532.73%
Oct 2532.73%
Oct 2527.27%
Oct 2527.27%
Oct 2532.73%
Oct 2527.27%
Sep 2535.73%
Sep 2547.63%
Sep 2547.63%
Sep 2547.63%
Aug 2535.73%
Aug 2535.73%
Aug 2547.63%
Aug 2535.73%
Aug 2535.73%
Jul 2547.63%
Jul 2547.63%
Jul 2547.63%
Jul 2547.63%
Jun 25-35.27%
Jun 25-35.27%
Jun 25-35.27%
Jun 25-35.27%
May 25-35.27%
May 25-35.27%
May 25-17.63%
May 25-17.63%
May 25-15.11%
Apr 25-17.63%
Apr 25-17.63%
Apr 25-17.63%
Apr 25-17.63%
Mar 251.13%
Mar 251.29%
Mar 251.51%
Mar 251.29%
Feb 251.29%
Feb 251.51%
Feb 251.51%
Feb 251.29%
Jan 251.29%
Jan 251.51%
Jan 251.29%
Jan 251.29%
Jan 251.29%
Dec 24-13.89%
Dec 24-13.89%
Dec 24-12.16%
Dec 24-13.89%
Nov 24-13.89%
Nov 24-13.89%
Nov 24-13.89%
Nov 24-12.16%
Nov 24-13.89%
Oct 24-13.89%
Oct 24-12.16%
Price to Sales
010203040med 12.15Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
APLI.TO Price to Sales by quarter
PeriodPrice to Sales
Sep 265.07
Sep 265.07
Aug 267.61
Aug 267.61
Aug 265.07
Aug 265.07
Jul 267.61
Jul 265.07
Jul 267.61
Jul 267.61
Jul 267.61
Jun 269.33
Jun 269.33
Jun 269.33
Jun 269.33
May 269.33
May 269.33
May 269.33
May 269.33
May 2612.44
Apr 269.33
Apr 269.33
Apr 269.33
Apr 2612.44
Mar 2612.15
Mar 269.11
Mar 2612.15
Mar 2612.15
Feb 269.11
Feb 2612.15
Feb 2612.15
Feb 2615.18
Jan 2615.18
Jan 2612.15
Jan 2612.15
Jan 2612.15
Jan 2615.18
Dec 2530.18
Dec 2524.15
Dec 2530.18
Dec 2530.18
Nov 2530.18
Nov 2530.18
Nov 2530.18
Nov 2530.18
Oct 2530.18
Oct 2536.22
Oct 2536.22
Oct 2530.18
Oct 2536.22
Sep 2524.15
Sep 2518.11
Sep 2518.11
Sep 2518.11
Aug 2524.15
Aug 2524.15
Aug 2518.11
Aug 2524.15
Aug 2524.15
Jul 2518.11
Jul 2518.11
Jul 2518.11
Jul 2518.11
Jun 2514.58
Jun 2514.58
Jun 2514.58
Jun 2514.58
May 2514.58
May 2514.58
May 2529.16
May 2529.16
May 2534.02
Apr 2529.16
Apr 2529.16
Apr 2529.16
Apr 2529.16
Mar 259.8
Mar 258.58
Mar 257.35
Mar 258.58
Feb 258.58
Feb 257.35
Feb 257.35
Feb 258.58
Jan 258.58
Jan 257.35
Jan 258.58
Jan 258.58
Jan 258.58
Dec 245.13
Dec 245.13
Dec 245.86
Dec 245.13
Nov 245.13
Nov 245.13
Nov 245.13
Nov 245.86
Nov 245.13
Oct 245.13
Oct 245.86
EV/EBITDA
35.53636.53737.5med 35.74Jul 25Jul 25Aug 25Aug 25Aug 25Sep 25Sep 25
APLI.TO EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2537.42
Sep 2535.74
Sep 2535.74
Sep 2535.74
Aug 2537.42
Aug 2537.42
Aug 2535.74
Aug 2537.42
Aug 2537.42
Jul 2535.74
Jul 2535.74
Jul 2535.74
Jul 2535.74
Price/Operating Cashflow
0255075100med 3.05Jan 25Feb 25Jul 25Aug 25Oct 25Nov 25Dec 25
APLI.TO Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Dec 253.05
Dec 252.44
Dec 253.05
Dec 253.05
Nov 253.05
Nov 253.05
Nov 253.05
Nov 253.05
Oct 253.05
Oct 253.66
Oct 253.66
Oct 253.05
Oct 253.66
Sep 252.79
Sep 252.09
Sep 252.09
Sep 252.09
Aug 252.79
Aug 252.79
Aug 252.09
Aug 252.79
Aug 252.79
Jul 252.09
Jul 252.09
Jul 252.09
Jul 252.09
Mar 2585.9
Mar 2575.16
Mar 2564.42
Mar 2575.16
Feb 2575.16
Feb 2564.42
Feb 2564.42
Feb 2575.16
Jan 2575.16
Jan 2564.42
Jan 2575.16
Jan 2575.16
Jan 2575.16
Price to Book
0255075100med 3.81Apr 20Jul 20Oct 20Feb 21May 21Sep 21Dec 21
APLI.TO Price to Book by quarter
PeriodPrice to Book
Dec 211.31
Dec 211.07
Dec 211.29
Dec 211.45
Nov 211.71
Nov 211.98
Nov 212.73
Nov 218.14
Oct 218.25
Oct 218.14
Oct 217.5
Oct 218.04
Oct 2110.82
Sep 214.66
Sep 214.71
Sep 214.27
Sep 214.27
Aug 213.73
Aug 213.78
Aug 213.44
Aug 213.63
Jul 213.98
Jul 213.49
Jul 213.44
Jul 213.44
Jul 213.49
Jun 212.65
Jun 212.76
Jun 213.04
Jun 213.04
May 213.08
May 213.01
May 214.12
May 214.48
Apr 214.23
Apr 213.58
Apr 213.76
Apr 213.72
Apr 213.83
Mar 212.93
Mar 212.93
Mar 213.02
Mar 212.81
Feb 213.13
Feb 213.51
Feb 213.87
Feb 213.4
Jan 212.93
Jan 213.31
Jan 213.28
Jan 213.4
Dec 203.57
Dec 202.63
Dec 202.8
Dec 202.76
Dec 202.67
Nov 202.76
Nov 202.5
Nov 202.65
Nov 203.44
Oct 203.2
Oct 203.07
Oct 203.2
Oct 203.15
Oct 203.26
Sep 205.51
Sep 205.29
Sep 204.8
Sep 204.13
Aug 203.42
Aug 204.13
Aug 204.18
Aug 204.13
Jul 204.13
Jul 204.31
Jul 204.62
Jul 205.02
Jul 204.36
Jun 2044.6
Jun 2046.89
Jun 2050.57
Jun 2051.95
May 2070.34
May 2077.7
May 2083.21
May 2068.5
May 2071.26
Apr 2062.07
Apr 2050.57
Apr 2044.14
Apr 2036.78
Mar 2012.73
Mar 2012.19
Mar 209.64
Mar 2010.91
Feb 2012.55
Feb 2014.37
Feb 2014.37
Feb 2016.37
Jan 2017.46
Appili Therapeutics Inc.
APLI.TO
Stockpicker

Video analysis: APLI.TO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.